Medical Products Firm Rises Near Pivot Point
Thursday, February 21, 2008 CANSLIM.net
Neogen Corp. |
|
Ticker Symbol: NEOG (NASDAQ) |
Industry Group: Medical- products |
Shares Outstanding: 14,300,000 |
Price: $27.34 3:02PM ET |
Day's Volume: 110,400 2/21/2008 3:02PM ET |
Shares in Float: 12,800,000 |
52 Week High: $28.00 2/21/2008 10:20AM ET |
50-Day Average Volume: 36,800 |
Up/Down Volume Ratio: 1.3 |
Pivot Point: $27.74 12/28/2008 plus $0.10 |
Pivot Point +5% = Max Buy Price: $29.13 |
Web Address: http://www.neogen.com/
|
C A N S L I M | StockTalk | News | Chart | SEC | Zacks Reports |
View all notes | Alert me of new notes | CANSLIM.net Company Profile
CANSLIM.net Profile: Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and sale a range of products for food safety testing and animal health applications. It was founded in 1981 and is based in Lansing, Michigan. It operates in two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary products that detect dangerous and/or unintended substances in human food and animal feed, such as food borne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues, and general sanitation concerns. This places the company in a strong position in the event the recent food recalls continue. The company offers its products directly, as well as through a network of national and international distributors, and large farm supply retail chains. It has operations in the United States, South America, Central America, Canada, Asia, and Europe. NEOG hails from the Medical-products group which is presently ranked 19th on the 197 Industry Groups list, which easily satisfies the L criteria. There were 24 top-rated funds with an ownership interest as of December '07, a sign of reasonable institutional interest. More encouraging, the stock has less than 13 million shares in the float, and having a small supply of shares is a characteristic that most of the greatest stock market winners exhibited before they enjoyed explosive moves up. Its annual earnings growth history has been steady but not especially strong, and quarterly earnings increases in the 4 latest quarterly earnings comparisons were borderline with the +25% guideline. Strong earnings increases are always preferred.
What to Look For and What to Look Out For: Look for the stock to confirm a new technical buy signal by breaking out and closing above its $27.74 pivot point with gains on heavy volume in the coming days and weeks. Remember that buyable breakouts require three important components: the stock must clear its pivot point with considerable gains, those gains must be backed by at least +50% above average volume, and the overall market environment must improve and produce a new batch of leadership. As always, it is of the utmost importance to sell a stock if it drops 7-8% below your purchase price. The small supply of outstanding shares could lead to dramatic price volatility, especially if the institutional crowd rushes in or out. Also, the market conditions are still somewhat questionable, largely due to the dearth of leadership, which suggests this is not an ideal environment conducive for accumulating shares. This high-ranked leader should remain on an active watchlist and could be considered as a new buy candidate in the event it closes above its pivot point on the necessary volume needed to trigger a technical buy signal.
Technical Analysis: NEOG technically traded up to a new all-time high with very heavy volume, and the gain has it now trading very near its pivot point. The bullish action prompted its appearance in yellow in today's CANSLIM.net Mid-Day BreakOuts Report (read here). Volume has easily surpassed the necessary threshold needed to trigger a technical buy signal, and a proper technical buy signal may be triggered if this leader closes above its pivot point with a gain on heavy volume. Neogen has spent the past 5 months building its latest base. The stock found great support near its 50-day moving average (DMA) line through many months of 2007, but during the market's January correction the stock violated its 50 DMA line and tested support at its longer-term 200 DMA line. It promptly found support and repaired the damage in recent weeks.
|
|
About :
Kenneth J. Gruneisen - Passed the CAN SLIMĀ® Master's Exam Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities.
You can contact Kenneth J. Gruneisen - Passed the CAN SLIMĀ® Master's Exam at kengruneisen@gmail.com
|
The information
and writings made
avaialable by individuals that successfully passed the CAN SLIM®
Masters Program are their own. Copyright © 1996-2024
Gruneisen Growth Corp. All rights reserved. Protected by the
copyright laws of the United States and Canada and by international
treaties.
|
|
|
|
|